Alzheimer’s in the Cross-Hairs

  • Biogen is one of the premier biotech companies in the world with dominant franchises in Multiple Sclerosis treatments and cancer.
  • With Alzheimer’s having the potential to bankrupt Medicare, will Biogen’s potential Alzheimer’s drug make it to FDA approval?
  • Has the biotech bear market created compelling value for Biogen Investors?
  • Will Biogen acquire other companies or itself be acquired?